Early Breast Cancer Clinical Trials in Bangkok
3 recruitingBangkok, Thailand
Showing 1–3 of 3 trials
Recruiting
Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer (Early Breast Cancer)
AstraZeneca5,500 enrolled794 locationsNCT05952557
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer (Early Breast Cancer)
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Not Applicable
Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms
Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Mahidol University206 enrolled1 locationNCT07448558